High-purity SS-31 (Elamipretide) is essential for achieving reproducible, unambiguous data in preclinical mitochondrial and cellular energetics research. PX1 Research supplies analytical-grade SS-31 verified via RP-HPLC, LC-MS, and rigorous endotoxin screening to maintain baseline stability across in vitro and animal models.
High-purity SS-31 (Elamipretide) is essential for achieving reproducible, unambiguous data in preclinical mitochondrial and cellular energetics research. PX1 Research supplies analytical-grade SS-31 verified via RP-HPLC, LC-MS, and rigorous endotoxin screening to maintain baseline stability across in vitro and animal models.
SS-31, also known as Elamipretide or Szeto-Schiller 31, is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) engineered to selectively target and concentrate within the inner mitochondrial membrane (IMM). Preclinical studies indicate that SS-31 interacts specifically with cardiolipin, an essential phospholipid crucial for maintaining cristae structure, electron transport chain (ETC) supercomplex organization, and efficient oxidative phosphorylation.
In laboratory investigations utilizing isolated mitochondria, cell culture assays, and rodent models, the functional integrity of SS-31 peptide depends entirely on molecular purity. Because this peptide targets fundamental bioenergetic machinery, minor chemical impurities or truncated side-products can disrupt baseline mitochondrial respiration, skew ROS quantification assays, and yield non-reproducible experimental outcomes.
Synthetic peptides generated via Solid-Phase Peptide Synthesis (SPPS) naturally accumulate minor side-products, including deletion sequences, racemized species, incomplete deprotection artifacts, and TFA salts. In biochemical assays evaluating mitochondrial membrane potential (ΔΨm) or ATP generation, even a 2% to 5% contamination level can alter assay sensitivity and create false-positive or false-negative signaling responses.
To ensure that observed biological phenomena stem exclusively from the target peptide sequence rather than synthetic artifacts, researchers must utilize compounds backed by full analytical characterization. Investigating complex metabolic cascades requires strict adherence to analytical purity standards, preventing unwanted cellular stress caused by non-target peptide fragments.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative method for determining the chemical purity of SS-31 purity lots. By passing the peptide through a hydrophobic stationary phase (typically C18 columns) under a gradient of polar and organic mobile phases (such as water/acetonitrile with 0.1% TFA), RP-HPLC separates the main product peak from closely related chemical impurities.
A rigorous HPLC analysis methods report displays the area under the curve (AUC) for every detected peak at a specific UV absorption wavelength (typically 214 nm or 220 nm, where peptide bonds absorb strongly). PX1 Research mandates that every production lot of SS-31 demonstrates a single predominant peak corresponding to standard retention time specifications, ensuring purity levels exceeding 98% or 99% with minimal background noise.
While RP-HPLC quantifies the relative concentration of the main peak, it cannot independently confirm the precise molecular weight or amino acid composition. Liquid Chromatography-Mass Spectrometry (LC-MS) couples physical separation with mass-to-charge (m/z) detection, providing absolute verification of SS-31 sequence identity.
The theoretical monoisotopic mass of SS-31 (C32H49N9O5, net charge considerations depending on ionization state) is precisely identified on electrospray ionization (ESI) spectra. High-resolution mass spectrometry confirms the presence of the correct precursor ion ([M+H]+ or multi-charged states) and verifies the absence of truncated deletion sequences that might co-elute under standard chromatographic conditions.
For quantitative in vitro studies—such as Seahorse XF flux analysis, microplate fluorescence ROS measurements, or isolated organelle swelling assays—the margin for experimental error is slim. Utilizing lower-purity peptides introduces unquantified variables that obscure subtle therapeutic mechanisms and shift dose-response curves unpredictably.
Maintaining a >99% purity threshold ensures that observed bioenergetic shifts correlate directly with cardiolipin binding and structural stabilization rather than unspecific peptide-membrane interactions. Researchers conducting high-throughput screening or publication-grade studies consistently rely on higher-grade material to eliminate lot-to-lot variance.
In cell culture models and tissue preparations, bacterial lipopolysaccharides (LPS), commonly referred to as endotoxins, pose a significant threat to experimental integrity. Endotoxins stimulate Toll-like receptor 4 (TLR4) pathways, inducing pro-inflammatory cytokine release and altering baseline cellular activity independently of the peptide being evaluated.
PX1 Research enforces stringent regulatory standards for bioburden management. Every lot of SS-31 undergoes quantitative Chromogenic LAL (Limulus Amebocyte Lysate) or Recombinant Factor C (rFC) testing. Implementing strict endotoxin testing in peptides ensures endotoxin levels remain well below standard cell-culture tolerance thresholds (<0.01 EU/μg), protecting sensitive primary cell cultures and organoid models from immune-mediated interference.
When designing protocols in the field of mitochondrial research peptides, investigators often compare SS-31 against other energetic regulators such as mots-c and humanin. While SS-31 works predominantly via direct physical interaction with cardiolipin inside the inner mitochondrial membrane, MOTS-c acts as a nuclear-encoded mitochondrial peptide that translocates to the nucleus to regulate metabolic transcription during stress.
Similarly, Humanin exhibits cytoprotective properties by binding signaling partners and inhibiting apoptotic pathways. Because these compounds operate through distinct mechanisms—cardiolipin structural stabilization vs. transcriptional regulation—evaluating them side-by-side in comparative assays requires absolute reagent purity to prevent cross-pathway artifacts.
Longitudinal research studies extending over months or years demand uncompromising lot-to-lot uniformity. A Certificate of Analysis (COA) must accompany every research compound, documenting specific testing parameters rather than generic target numbers.
PX1 Research provides full analytical transparency by utilizing independent ISO 17025 accredited testing laboratories. Each COA includes complete HPLC chromatograms, LC-MS spectra, appearance validation, solubility profiles, and mass spectrometry confirmation. Researchers can access these documents directly through our research library to verify lot details before initiating crucial experimental runs.
SS-31 is supplied as a lyophilized (freeze-dried) trifluoroacetate or acetate salt to maximize long-term stability during transit and storage. Lyophilized powder should be stored at -20°C or -80°C in a desiccated environment upon receipt to prevent hydrolytic degradation.
When preparing stock solutions for laboratory assays, researchers should reconstitute SS-31 in sterile, deionized water or buffered saline (PBS, pH 7.4) under sterile laminar flow conditions. Reviewing a comprehensive peptide reconstitution guide helps avoid common pitfalls such as violent agitation, repeated freeze-thaw cycles, or improper pH conditions that compromise peptide solubility and peptide stability.
Securing high-purity research compounds from reliable suppliers is a prerequisite for reproducible scientific discoveries. PX1 Research synthesizes peptides in state-of-the-art USA-based facilities adhering to cGMP guidelines and rigorous quality management frameworks.
Whether executing small-scale pilot studies or large-scale institutional screening programs requiring bulk peptide sourcing, PX1 Research offers standard overnight shipping options from our CA and AZ facilities to maintain cold-chain integrity and rapid order fulfillment.
What analytical techniques are used to verify SS-31 purity?
SS-31 purity is primarily verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity percentage, and Liquid Chromatography-Mass Spectrometry (LC-MS) to verify exact molecular weight and sequence identity.
Why is endotoxin testing critical for SS-31 research peptides?
Bacterial endotoxins can induce unwanted inflammatory signaling via TLR4 pathways in cell culture and tissue models, causing non-specific responses that mask or distort the actual biological effects of SS-31.
How should lyophilized SS-31 be stored in the laboratory?
Lyophilized SS-31 powder should be stored at -20°C or -80°C in a dry environment away from light. Reconstituted aliquots should be frozen immediately to prevent degradation from repeated freeze-thaw cycles.
What is the acceptable purity threshold for preclinical SS-31 assays?
For robust, publication-grade preclinical research, a purity threshold of ≥98% to ≥99% is recommended to ensure that measured bioenergetic responses stem directly from the peptide rather than synthesis impurities.
Does PX1 Research provide lot-specific Certificates of Analysis (COA)?
Yes. Every lot of SS-31 supplied by PX1 Research includes a lot-specific COA featuring raw HPLC chromatograms, LC-MS spectra, and quantitative endotoxin test results from independent ISO 17025 accredited laboratories.
How does SS-31 differ structurally from peptides like MOTS-c?
SS-31 is a small synthetic tetrapeptide containing non-natural amino acids (such as dimethyltyrosine) designed to target cardiolipin in the inner mitochondrial membrane, whereas MOTS-c is a 16-amino-acid mitochondrial-derived peptide involved in metabolic gene regulation.
Can SS-31 be reconstituted in standard phosphate-buffered saline (PBS)?
Yes, SS-31 readily dissolves in sterile water or PBS (pH 7.4) for in vitro and laboratory assays. Researchers should gently invert or swirl the vial rather than vortexing vigorously.
Where are PX1 Research peptides synthesized and shipped from?
All PX1 Research compounds are synthesized in state-of-the-art facilities and dispatched directly from distribution hubs in California and Arizona with same-day fulfillment options for institutional accounts.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.